Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
Tanaka K, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kusagaya H, Matsuura S, Uto T, Hashimoto D, Matsui T, Asada K, Suda T.
Tanaka K, et al. Among authors: matsui t.
Cancer Chemother Pharmacol. 2019 Jul;84(1):147-153. doi: 10.1007/s00280-019-03868-5. Epub 2019 May 13.
Cancer Chemother Pharmacol. 2019.
PMID: 31087137
Clinical Trial.